Larglustat 84mg Capsule contains Eliglustat, an oral substrate-reduction therapy (SRT) used for the long-term treatment of Gaucher disease type 1. Gaucher disease is a rare, inherited metabolic disorder caused by a deficiency of the enzyme β-glucocerebrosidase. This deficiency leads to the accumulation of a fatty substance called glucosylceramide in organs such as the liver, spleen, and bone marrow, resulting in anaemia, enlarged organs, bone pain, and fatigue. Eliglustat works by reducing the production of glucosylceramide, helping restore balance between the production and breakdown of this lipid. It is prescribed for adult patients who are CYP2D6 extensive or intermediate metabolizers, as confirmed through genetic testing. Larglustat 84mg Capsule is not a cure, but it serves as an effective long-term therapy for stabilising and improving symptoms when taken consistently. Patients must complete metabolic and genetic assessments before starting treatment. It is contraindicated in individuals with known hypersensitivity to Eliglustat or similar agents, and caution is required in those with pre-existing cardiac conditions or those taking medications that affect liver enzymes. For individuals comparing costs, the Larglustat 84mg Capsule price may vary depending on availability and pharmacy location.